Nalaganje...
Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma
Sorafenib is an oral multiple kinase inhibitor that blocks Raf, vascular endothelial growth factor receptor, and platelet-derived growth factor receptor. It has been approved in the US and Europe for the treatment of advanced hepatocellular carcinoma (HCC). Sorafenib has demonstrated a 44% increase...
Shranjeno v:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2010
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3846497/ https://ncbi.nlm.nih.gov/pubmed/24367212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/HMER.S7123 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|